Post-market Review of biological Disease Modifying Anti-Rheumatic Drugs to treat Severe Chronic Plaque Psoriasis and of Pulmonary Arterial Hypertension Medicines – Public Consultation
Page last updated: 19 August 2016
The public consultation process on the draft Terms of Reference is closed for the Post-market Reviews of:
- biological Disease Modifying Anti‑Rheumatic Drugs (bDMARDs) to treat Severe Chronic Plaque Psoriasis
- Pulmonary Arterial Hypertension (PAH) Medicines.
The Department appreciates the contributions of all organisations and individuals who made a submission.
Submissions commenting on the draft Terms of Reference have been published on the PBS website for: